Leap Investments’s Twist Bioscience TWST Stock Holding History

Leap Investments’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,491	Closed	-$394K	–	589
2019 Q3	$394K	Buy	+16,491	New	+$479K	0.2%	188

Other funds holding TWST

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Leap Investments's TWST Position: Q4 2019 in Review

Leap Investments sold out of Twist Bioscience (TWST) in Q4 2019, closing a stake of 16,491 shares — an estimated $394K sold.

Leap Investments first reported a position in TWST in Q3 2019 and held it in 1 quarter. The position peaked at $394K in Q3 2019. 93 funds tracked by Wall St. Rank hold TWST as of Q4 2019.

Leap Investments reported no remaining Twist Bioscience position as of Q4 2019 after selling out during the quarter.
Leap Investments sold 16,491 Twist Bioscience shares in Q4 2019, an estimated $394K.
Leap Investments first reported a position in Twist Bioscience in Q3 2019 and held it in 1 quarter.
Leap Investments's Twist Bioscience position peaked at $394K in Q3 2019.
93 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2019.

Based on Leap Investments's 13F filing for Q4 2019, filed 14 Feb 2020.